Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-10-24

FDA Approved: PENTASA — Supplemental Application (Takeda Pharmaceuticals America, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for Pentasa (mesalamine) from Takeda Pharmaceuticals America, Inc., enabling changes to its labeling and/or approved…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PENTASA (MESALAMINE)

Snippet

SUPPL AP for PENTASA (MESALAMINE)